Abstract:Photodynamic therapy (PDT) brings new hope for the treatment of breast cancer due to few side effects and highly effective cell killing; however, the low bioavailability of traditional photosensitizers and their dependence on oxygen severely limits their application. Aggregation-induced emission (AIE) photosensitizers (PSs) can dramatically facilitate the photosensitization effect, which can have positive impacts on tumor PDT. To-date, most AIE photosensitizers lack tumor targeting capability and possess poor cell delivery, resulting in their use in large quantities that are harmful to healthy tissues. In this study, a series of AIE photosensitizers based on pyridinium-substituted triphenylamine salts (abbreviated to TTPAs 1 - 6 ) with different alkyl chain lengths are synthesized. Results reveal that TTPAs 1 - 6 promote the generation of type I and type II reactive oxygen species (ROS), including ·OH and 1 O 2 . In particular, the membrane permeability and targeting of TTPAs 4 - 6 bearing C8-C10 side-chains are higher than TTPAs 1 - 3 bearing shorter alkyl chains. Additionally, they can assemble with albumin, thereby forming nanoparticles (TTPA 4 - 6 NPs) in situ in blood, which significantly facilitates mitochondrial-targeting and strong ROS generation ability. Moreover, the TTPA 4-6 nanoparticles are pH-responsive, allowing for increased accumulation or endocytosis of the tumor and enhancing the imaging or therapeutic effect. Therefore, the in vivo distributions of TTPA 4 - 6 nanoparticles are visually enriched in tumor sites and exhibited excellent photodynamic cancer therapy efficacy. This work demonstrates a novel strategy for AIE PDT and has the potential to play an essential role in clinical applications using nano-delivery systems. Graphical A series of AIE photosensitizers assembling with albumin to form nanoparticles, which exhibits excellent ability of ROS generation. Additionally, these nanoparticles demonstrates outstanding tumor targeting and photodynamic cancer therapy effect. Download: Download high-res image (404KB) Download: Download full-size image

In vitro and in vivo evaluation of a chlorin-based photosensitizer KAE® for cancer treatment

Anti-tumor evaluation of a novel methoxyphenyl substituted chlorin photosensitizer for photodynamic therapy

Design, Synthesis and Biological Evaluation of Novel 31-Hexyloxy Chlorin E6-Based 152- or 131-Amino Acid Derivatives As Potent Photosensitizers for Photodynamic Therapy.

Unusual Electron Donor-Acceptor Sequenced NIR AIEgen for Highly Efficient Mitochondria-Targeted Cancer Cell Photodynamic Therapy.

Photocyanine: A Novel and Effective Phthalocyanine-Based Photosensitizer for Cancer Treatment

EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer

On the mechanisms of photodynamic action of photosensitizers based on polycationic derivatives of synthetic bacteriochlorin against human lung cancer cells A549 (in vitro study)

Recent Advances in Developing Photosensitizers for Photodynamic Cancer Therapy

Photosensitizer Used in Clinical Photodynamic Thearpy for Cancer

Construction and Evaluation of a Targeted Hyaluronic Acid Nanoparticle/Photosensitizer Complex for Cancer Photodynamic Therapy.

Alkyl chain length-regulated in situ intelligent nano-assemblies with AIE-active photosensitizers for photodynamic cancer therapy

Research Progress of Natural Product Photosensitizers in Photodynamic Therapy

Rational Design of a High-Performance Quinoxalinone-Based AIE Photosensitizer for Image-Guided Photodynamic Therapy.

In Vivo Biocompatibility, Biodistribution and Therapeutic Efficiency of Titania Coated Upconversion Nanoparticles for Photodynamic Therapy of Solid Oral Cancers.

In Vitro and in Vivo Antitumor Activity of a Novel Hypocrellin B Derivative for Photodynamic Therapy.

Folic Acid-Conjugated Pyropheophorbide A As the Photosensitizer Tested for in Vivotargeted Photodynamic Therapy

Nanobody modified high-performance AIE photosensitizer nanoparticles for precise photodynamic oral cancer therapy of patient-derived tumor xenograft

Photodynamic Therapy in the Treatment of Cancer—The Selection of Synthetic Photosensitizers

Photodynamic Therapy for Field Cancerization in the Skin: Where Do We Stand?

Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical

A Phase Ι Study to Evaluate the Application of Photocyanine Using Pharmacokinetic and Pharmacodynamic Analysis in Patients with Malignancy